Prognostic markers in pediatric leukemia and mechanisms of KRAS induced leukemogenesis

Colin J. Davidson, Emily Zeringer, Kristen J. Champion, Marie-Pierre Gauthier, Fawn Wang, Jerry Boonyaratanakornkit, Julie R. Jones, Edgar Schreiber, Improving the limit of detection for Sanger sequencing: a comparison of methodologies for KRAS variant detection. BioTechniques. ,vol. 53, pp. 182- 188 ,(2012) , 10.2144/000113913

K.A. Swan, J. Alberola-Ila, J.A. Gross, M.W. Appleby, K.A. Forbush, J.F. Thomas, R.M. Perlmutter, INVOLVEMENT OF P21RAS DISTINGUISHES POSITIVE AND NEGATIVE SELECTION IN THYMOCYTES The EMBO Journal. ,vol. 14, pp. 276- 285 ,(1995) , 10.1002/J.1460-2075.1995.TB07001.X

K.L. MacKenzie, A. Dolnikov, M. Millington, Y. Shounan, G. Symonds, Mutant N-ras Induces Myeloproliferative Disorders and Apoptosis in Bone Marrow Repopulated Mice Blood. ,vol. 93, pp. 2043- 2056 ,(1999) , 10.1182/BLOOD.V93.6.2043.406K17_2043_2056

T Skorski, P Kanakaraj, M Nieborowska-Skorska, MZ Ratajczak, SC Wen, G Zon, AM Gewirtz, B Perussia, B Calabretta, Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells Blood. ,vol. 86, pp. 726- 736 ,(1995) , 10.1182/BLOOD.V86.2.726.BLOODJOURNAL862726

Patrick S. Ward, The common feature of cancer-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to the oncometabolite 2-hydroxyglutarate ,(2013)

L. King-Underwood, K. Pritchard-Jones, Wilms' Tumor (WT1) Gene Mutations Occur Mainly in Acute Myeloid Leukemia and May Confer Drug Resistance Blood. ,vol. 91, pp. 2961- 2968 ,(1998) , 10.1182/BLOOD.V91.8.2961.2961_2961_2968

S C Raimondi, Y Ravindranath, H J Weinstein, M V Gresik, F G Behm, C P Steuber, A J Carroll, M N Chang, Chromosomal abnormalities in 478 children with acute myeloid leukemia: clinical characteristics and treatment outcome in a cooperative pediatric oncology group study-POG 8821. Blood. ,vol. 94, pp. 3707- 3716 ,(1999) , 10.1182/BLOOD.V94.11.3707

Tamara Vukosavljevic, Peter Paschka, Krzysztof Mrózek, Michael D. Radmacher, Claudia D. Baldus, Christian Langer, Amy S. Ruppert, Susan P. Whitman, Chang-Gong Liu, L. Powell, Albert de la Chapelle, Richard A. Larson, Mary E. Ross, Jonathan E. Kolitz, Guido Marcucci, myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study cytogenetically normal patients younger than 60 years with acute markers, poor outcome, and a distinct gene-expression signature in High BAALC expression associates with other molecular prognostic ,(2013)

Cancer Genome Atlas Research Network, None, Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia The New England Journal of Medicine. ,vol. 368, pp. 2059- 2074 ,(2013) , 10.1056/NEJMOA1301689

E.C. Zwarthoff, P.H.J. Riegman, D.C. van der Plas, A.H.M. Geurts van Kessel, S. van Baal, R. Lekanne Deprez, S. Sherr, G. Grosveld, S. van Bezouw, A.J. Buijs, A. Hagemeijer, Translocation (12;22)(p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11 Oncogene. ,vol. 10, pp. 1511- 1519 ,(1995)